Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Mar 1;378(Pt 2):673–679. doi: 10.1042/BJ20031765

A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.

Tatjana Arsenijevic 1, Chantal Degraef 1, Jacques E Dumont 1, Pierre P Roger 1, Isabelle Pirson 1
PMCID: PMC1223988  PMID: 14641107

Abstract

Using a yeast interaction screen to search for proteins that interact with cyclin D3 in thyroid gland, we identified the cAMP-dependent AKAP95 (protein kinase A-anchoring protein 95). AKAP95 is a scaffolding protein that primarily co-fractionates with the nuclear matrix, whereas a minor fraction associates with chromatin in interphase cells. In co-transfected Chinese-hamster ovary cells, AKAP95 strongly interacted with the three D-type cyclins, but not with CDK4 (cyclin-dependent kinase 4) or with p27kip1. CDK4 displaced the interaction between cyclin D3 and AKAP95, suggesting that AKAP95 could not be the elusive bridging adaptor between D-type cyclins and CDK4 or play a role in the regulation of cyclin D3-CDK4 activity. Interaction between endogenous AKAP95 and cyclin D3 or cyclin D1 was detected in canine thyrocytes, human fibroblasts and NIH-3T3 cells. As both AKAP95 and cyclins D were recently reported to associate with minichromosome maintenance proteins [Eide, Tasken, Carlson, Williams, Jahnsen, Tasken and Collas (2003) J. Biol. Chem. 278, 26750-26756; Gladden and Diehl (2003) J. Biol. Chem. 278, 9754-9760], we hypothesize that the interaction between AKAP95 and D-type cyclins might serve to facilitate the emerging regulatory role of cyclin D-CDK4 in the formation of the prereplication complex at the DNA replication origins.

Full Text

The Full Text of this article is available as a PDF (289.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akileswaran L., Taraska J. W., Sayer J. A., Gettemy J. M., Coghlan V. M. A-kinase-anchoring protein AKAP95 is targeted to the nuclear matrix and associates with p68 RNA helicase. J Biol Chem. 2001 Feb 22;276(20):17448–17454. doi: 10.1074/jbc.M101171200. [DOI] [PubMed] [Google Scholar]
  2. Bagui T. K., Jackson R. J., Agrawal D., Pledger W. J. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol. 2000 Dec;20(23):8748–8757. doi: 10.1128/mcb.20.23.8748-8757.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol. 1996 Dec;8(6):805–814. doi: 10.1016/s0955-0674(96)80081-0. [DOI] [PubMed] [Google Scholar]
  4. Bartkova J., Zemanova M., Bartek J. Abundance and subcellular localisation of cyclin D3 in human tumours. Int J Cancer. 1996 Jan 26;65(3):323–327. doi: 10.1002/(SICI)1097-0215(19960126)65:3<323::AID-IJC8>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  5. Beijersbergen R. L., Carlée L., Kerkhoven R. M., Bernards R. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 1995 Jun 1;9(11):1340–1353. doi: 10.1101/gad.9.11.1340. [DOI] [PubMed] [Google Scholar]
  6. Blain S. W., Montalvo E., Massagué J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem. 1997 Oct 10;272(41):25863–25872. doi: 10.1074/jbc.272.41.25863. [DOI] [PubMed] [Google Scholar]
  7. Cheng M., Olivier P., Diehl J. A., Fero M., Roussel M. F., Roberts J. M., Sherr C. J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999 Mar 15;18(6):1571–1583. doi: 10.1093/emboj/18.6.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cheng M., Sexl V., Sherr C. J., Roussel M. F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1091–1096. doi: 10.1073/pnas.95.3.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coghlan V. M., Langeberg L. K., Fernandez A., Lamb N. J., Scott J. D. Cloning and characterization of AKAP 95, a nuclear protein that associates with the regulatory subunit of type II cAMP-dependent protein kinase. J Biol Chem. 1994 Mar 11;269(10):7658–7665. [PubMed] [Google Scholar]
  10. Collas P., Le Guellec K., Taskén K. The A-kinase-anchoring protein AKAP95 is a multivalent protein with a key role in chromatin condensation at mitosis. J Cell Biol. 1999 Dec 13;147(6):1167–1180. doi: 10.1083/jcb.147.6.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coulonval Katia, Bockstaele Laurence, Paternot Sabine, Dumont Jacques E., Roger Pierre P. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp Cell Res. 2003 Nov 15;291(1):135–149. doi: 10.1016/s0014-4827(03)00392-6. [DOI] [PubMed] [Google Scholar]
  12. Depoortere F., Dumont J. E., Roger P. P. Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J Cell Sci. 1996 Jul;109(Pt 7):1759–1764. doi: 10.1242/jcs.109.7.1759. [DOI] [PubMed] [Google Scholar]
  13. Depoortere F., Pirson I., Bartek J., Dumont J. E., Roger P. P. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell. 2000 Mar;11(3):1061–1076. doi: 10.1091/mbc.11.3.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Depoortere F., Van Keymeulen A., Lukas J., Costagliola S., Bartkova J., Dumont J. E., Bartek J., Roger P. P., Dremier S. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol. 1998 Mar 23;140(6):1427–1439. doi: 10.1083/jcb.140.6.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Despouy Gilles, Bastie Jean-Nöel, Deshaies Sylvie, Balitrand Nicole, Mazharian Alexandra, Rochette-Egly Cécile, Chomienne Christine, Delva Laurent. Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J Biol Chem. 2002 Dec 12;278(8):6355–6362. doi: 10.1074/jbc.M210697200. [DOI] [PubMed] [Google Scholar]
  16. Eide T., Coghlan V., Orstavik S., Holsve C., Solberg R., Skâlhegg B. S., Lamb N. J., Langeberg L., Fernandez A., Scott J. D. Molecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95. Exp Cell Res. 1998 Feb 1;238(2):305–316. doi: 10.1006/excr.1997.3855. [DOI] [PubMed] [Google Scholar]
  17. Eide Turid, Taskén Kristin A., Carlson Cathrine, Williams Gareth, Jahnsen Tore, Taskén Kjetil, Collas Philippe. Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication. J Biol Chem. 2003 May 9;278(29):26750–26756. doi: 10.1074/jbc.M300765200. [DOI] [PubMed] [Google Scholar]
  18. El Housni H., Vandenbroere I., Perez-Morga D., Christophe D., Pirson I. A rare case of false positive in a yeast two-hybrid screening: the selection of rearranged bait constructs that produce a functional gal4 activity. Anal Biochem. 1998 Aug 15;262(1):94–96. doi: 10.1006/abio.1998.2804. [DOI] [PubMed] [Google Scholar]
  19. Farkas Thomas, Hansen Klaus, Holm Karin, Lukas Jiri, Bartek Jiri. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J Biol Chem. 2002 May 2;277(30):26741–26752. doi: 10.1074/jbc.M200381200. [DOI] [PubMed] [Google Scholar]
  20. Furusawa Makoto, Taira Takahiro, Iguchi-Ariga Sanae M. M., Ariga Hiroyoshi. AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex. J Biol Chem. 2002 Oct 31;277(52):50885–50892. doi: 10.1074/jbc.M206387200. [DOI] [PubMed] [Google Scholar]
  21. Gladden Andrew B., Diehl J. Alan. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding. J Biol Chem. 2003 Jan 7;278(11):9754–9760. doi: 10.1074/jbc.M212088200. [DOI] [PubMed] [Google Scholar]
  22. Hansen K., Farkas T., Lukas J., Holm K., Rönnstrand L., Bartek J. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block. EMBO J. 2001 Feb 1;20(3):422–432. doi: 10.1093/emboj/20.3.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kato J. Y., Matsuoka M., Strom D. K., Sherr C. J. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol. 1994 Apr;14(4):2713–2721. doi: 10.1128/mcb.14.4.2713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kimura T., Van Keymeulen A., Golstein J., Fusco A., Dumont J. E., Roger P. P. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev. 2001 Oct;22(5):631–656. doi: 10.1210/edrv.22.5.0444. [DOI] [PubMed] [Google Scholar]
  25. Kitagawa M., Higashi H., Jung H. K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 1996 Dec 16;15(24):7060–7069. [PMC free article] [PubMed] [Google Scholar]
  26. LaBaer J., Garrett M. D., Stevenson L. F., Slingerland J. M., Sandhu C., Chou H. S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997 Apr 1;11(7):847–862. doi: 10.1101/gad.11.7.847. [DOI] [PubMed] [Google Scholar]
  27. Lamb J., Ladha M. H., McMahon C., Sutherland R. L., Ewen M. E. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol Cell Biol. 2000 Dec;20(23):8667–8675. doi: 10.1128/mcb.20.23.8667-8675.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Landsverk H. B., Carlson C. R., Steen R. L., Vossebein L., Herberg F. W., Taskén K., Collas P. Regulation of anchoring of the RIIalpha regulatory subunit of PKA to AKAP95 by threonine phosphorylation of RIIalpha: implications for chromosome dynamics at mitosis. J Cell Sci. 2001 Sep;114(Pt 18):3255–3264. doi: 10.1242/jcs.114.18.3255. [DOI] [PubMed] [Google Scholar]
  29. Leng Xiaohong, Noble Martin, Adams Peter D., Qin Jun, Harper J. Wade. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol Cell Biol. 2002 Apr;22(7):2242–2254. doi: 10.1128/MCB.22.7.2242-2254.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lundberg A. S., Weinberg R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol. 1998 Feb;18(2):753–761. doi: 10.1128/mcb.18.2.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Matsushime H., Quelle D. E., Shurtleff S. A., Shibuya M., Sherr C. J., Kato J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 1994 Mar;14(3):2066–2076. doi: 10.1128/mcb.14.3.2066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Neuman E., Ladha M. H., Lin N., Upton T. M., Miller S. J., DiRenzo J., Pestell R. G., Hinds P. W., Dowdy S. F., Brown M. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol. 1997 Sep;17(9):5338–5347. doi: 10.1128/mcb.17.9.5338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Paternot Sabine, Coulonval Katia, Dumont Jacques E., Roger Pierre P. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J Biol Chem. 2003 Apr 30;278(29):26533–26540. doi: 10.1074/jbc.M302492200. [DOI] [PubMed] [Google Scholar]
  34. Reutens A. T., Fu M., Wang C., Albanese C., McPhaul M. J., Sun Z., Balk S. P., Jänne O. A., Palvimo J. J., Pestell R. G. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol. 2001 May;15(5):797–811. doi: 10.1210/mend.15.5.0641. [DOI] [PubMed] [Google Scholar]
  35. Reynisdóttir I., Massagué J. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 1997 Feb 15;11(4):492–503. doi: 10.1101/gad.11.4.492. [DOI] [PubMed] [Google Scholar]
  36. Roger P. P., Servais P., Dumont J. E. Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. J Cell Physiol. 1987 Jan;130(1):58–67. doi: 10.1002/jcp.1041300110. [DOI] [PubMed] [Google Scholar]
  37. Sherr C. J. D-type cyclins. Trends Biochem Sci. 1995 May;20(5):187–190. doi: 10.1016/s0968-0004(00)89005-2. [DOI] [PubMed] [Google Scholar]
  38. Sherr C. J., Roberts J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999 Jun 15;13(12):1501–1512. doi: 10.1101/gad.13.12.1501. [DOI] [PubMed] [Google Scholar]
  39. Soos T. J., Kiyokawa H., Yan J. S., Rubin M. S., Giordano A., DeBlasio A., Bottega S., Wong B., Mendelsohn J., Koff A. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 1996 Feb;7(2):135–146. [PubMed] [Google Scholar]
  40. Sterner J. M., Dew-Knight S., Musahl C., Kornbluth S., Horowitz J. M. Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol. 1998 May;18(5):2748–2757. doi: 10.1128/mcb.18.5.2748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sugimoto Masataka, Martin Nicholas, Wilks Deepti P., Tamai Katsuyuki, Huot Thomas J. G., Pantoja Cristina, Okumura Ko, Serrano Manuel, Hara Eiji. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene. 2002 Nov 21;21(53):8067–8074. doi: 10.1038/sj.onc.1206019. [DOI] [PubMed] [Google Scholar]
  42. Tassan J. P., Schultz S. J., Bartek J., Nigg E. A. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol. 1994 Oct;127(2):467–478. doi: 10.1083/jcb.127.2.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Van Keymeulen A., Bartek J., Dumont J. E., Roger P. P. Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene. 1999 Dec 2;18(51):7351–7359. doi: 10.1038/sj.onc.1203164. [DOI] [PubMed] [Google Scholar]
  44. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem. 1997 May 9;272(19):12738–12746. doi: 10.1074/jbc.272.19.12738. [DOI] [PubMed] [Google Scholar]
  45. Zwijsen R. M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R. J. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 1997 Feb 7;88(3):405–415. doi: 10.1016/s0092-8674(00)81879-6. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES